Dilip Surana, Chairman and MD, Microlabs Limited
Disciplined and Persistent is how Mr. Dilip Surana likes to describe himself. He is a firm believer that their success is the outcome of continued focus and hard work. His father, late Shri G.C.Surana, founded and established Micro Labs in 1973. Micro Labs is a fully integrated pharmaceutical company that encompasses all aspects of the pharmaceutical value chain from Research and Development, Active Pharmaceutical Ingredients, Finished formulations, to Marketing and Distribution in India and overseas.
ABOUT THE LEADING LIGHT
Born on 18th January 1966 in Bangalore, Dilip Surana completed his schooling at Bishop Cotton Boys High School in Bangalore and further graduated in 1987 with a Bachelor of Commerce (Accounts) degree from St. Joseph's College of Commerce-Bangalore University. He is the eldest brother and eventually went on to join the business started by his father Shri G.C. Surana in 1988. Formerly under the leadership of late Mr. G. C. Surana, the privately held company is now run by Mr. Dilip Surana & Mr. Anand Surana. He cherishes every moment, but to him, the time he spent learning ropes from his father is what he treasures the most. And as he further advises budding entrepreneurs he says, “Work Hard, Result will follow and do not Compromise on Quality” The company ranks among the top 20 in India as per AIOCD-AWACS October 2021, with a presence in more than 50 countries and 3300 product registrations at various stages.
“My passion is not just to be best, but a leader in development, manufacture, and marketing of pharmaceutical products”
Mr. Dilip is in the Global Pharmaceutical business, and loves everything about his job, from interacting with his employees, doctors, trade partners, industry colleagues & leaders, to learning from the market, visiting manufacturing, and R&D.
CHALLENGES, RISKS AND VANQUISH
Covid Pandemic posed one of the most challenging times for all professionals globally. As soon as the lockdown began, he set up a core team of senior officials. Their core team managed to work remotely and work in shifts while maintaining all safety measures in compliance with WHO guidelines.
"Success is measured by others, and success means holistic expansion of the company in every sphere."
Their special drives promoting nation-building set them apart. Knowledge fuels success is what the Surana Educational Institutions speak for. Being at the forefront of social contribution, they strive to be a model corporate citizen in terms of environmental protection and social initiatives with significant contributions in the fields of education and healthcare. The GDA Foundation was established by Micro Labs in 1994, which oversees several educational institutions involving an undergraduate college, a management college, a school called Surana Vidyalaya, as well as helping some clinics and hospitals.
“Work is Worship and a place of Worship is always strength” Shree Parshwa Susheel Dham, (Swetamber Jain Temple), the slated Jain Tirth Sthan was built on Hosur Road, at Attibele, 15 minutes from Electronic City in Bangalore is an astounding Tirth work by Surana’s of Micro Labs. Shankeshwar Parshwanath is the mulnayak or essential God here, as well as the Dadavadi of Sushil Suriji marasaheb. Additionally, this tirth features images of Bhomiyaji Maharaj, Ghantakarna Mahaveer, Padmavati Mata, and Nakoda Bheruji. All front lines of the tirth have Dharamshala, bhojanshalas, and a playground for children's amusement. Shree Parshwa Susheel Dham stands apart from other nearby sanctuaries and draws visitors from around the world, who enjoy and get immersed in its tranquil environment.
PRESENT INDUSTRY SCENARIO
In its current state, the Indian Pharmaceutical Industry is well-positioned to continue to sustain its status as a leading player in the global pharmaceutical industry with a value and quality-based presence. A report from Ernst and Young estimates the Indian Pharmaceutical Industry to reach USD 130 billion by 2030.
ACHIEVEMENTS & ACCREDITATIONS
§ IPR Leadership Award 2020 for Excellence Contribution in the field of Patents
§ The Micro Labs Sikkim manufacturing unit was consequently awarded the prestigious Gold award in the years 2017, 2018, and 2019, and a Silver award in the year 2016 at the Indian Manufacturing Excellence Awards (IMEA) held by Frost and Sullivan in association with Economic Times.
§ Sikkim Unit got the feather in the cap by achieving accolade from Indian Drug Manufacturers Association (IDMA), Quality Excellence Award with a clean hat-trick of Gold Award for the year 2017, 2018, and 2019, and Silver Award for the year 2016
§ In 2019 and 2021, Dolo-650 was awarded the Times award for most popular and trusted pharmaceutical brand
Their plants have been recognized with International Accreditations:
§ 4 sites approved by UK MHRA (MRP with other European Union member states)
§ 2 sites approved by Health Canada
§ 4 sites approved US FDA
§ There are 2 approved sites and 2 awaiting approval by WHO
FUTURE BUSINESS PROSPECTS
Their domestic market will continue to receive their focus and investments as they have ample opportunities to increase their market share. A brand with state-of-the-art facilities and research centers built to international standards, Micro Labs is poised to become a global brand in the pharmaceutical sector and enhance the country's growing reputation. Globally they will grow on the existing robust area and increase presence in the US and Europe. Micro Labs is Marching Ahead to Build a Healthier Tomorrow, “Because Health is in Small Details”.